Collegium Pharmaceutical acquired Azstarys for $650 million and noted learning from Horizon Therapeutics' growth model.
1 report, 1 independent
Updated Aug 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Collegium Pharmaceutical acquired Azstarys for $650 million and noted learning from Horizon Therapeutics' growth model.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Horizon Therapeutics
Irish tax-registered pharmaceutical
Nothing else this week.